These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32247966)
1. Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations. Lai HJ; Lai WT; Jin L; Kuo KT; Lee MJ J Neurol Sci; 2020 Jun; 413():116810. PubMed ID: 32247966 [TBL] [Abstract][Full Text] [Related]
2. Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser. Kan HW; Chiang H; Lin WM; Yu IS; Lin SW; Hsieh ST Neuropathol Appl Neurobiol; 2018 Dec; 44(7):673-686. PubMed ID: 29423915 [TBL] [Abstract][Full Text] [Related]
3. The Temporal Profiles of Changes in Nerve Excitability Indices in Familial Amyloid Polyneuropathy. Lai HJ; Chiang YW; Yang CC; Hsieh ST; Chao CC; Lee MJ; Kuo CC PLoS One; 2015; 10(11):e0141935. PubMed ID: 26529114 [TBL] [Abstract][Full Text] [Related]
4. A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy. Murakami T; Yokoyama T; Mizuguchi M; Toné S; Takaku S; Sango K; Nishimura H; Watabe K; Sunada Y J Neurochem; 2021 Mar; 156(6):957-966. PubMed ID: 32852783 [TBL] [Abstract][Full Text] [Related]
6. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model. Gonçalves NP; Teixeira-Coelho M; Saraiva MJ Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914 [TBL] [Abstract][Full Text] [Related]
7. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615 [TBL] [Abstract][Full Text] [Related]
8. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo. Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467 [TBL] [Abstract][Full Text] [Related]
9. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD. Teixeira AC; Saraiva MJ J Cell Mol Med; 2013 Mar; 17(3):429-35. PubMed ID: 23387326 [TBL] [Abstract][Full Text] [Related]
10. Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy. Gonçalves NP; Teixeira-Coelho M; Saraiva MJ J Neuropathol Exp Neurol; 2015 Mar; 74(3):203-17. PubMed ID: 25668561 [TBL] [Abstract][Full Text] [Related]
11. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058 [TBL] [Abstract][Full Text] [Related]
12. Biophysical characterization and modulation of Transthyretin Ala97Ser. Liu YT; Yen YJ; Ricardo F; Chang Y; Wu PH; Huang SJ; Lin KP; Yu TY Ann Clin Transl Neurol; 2019 Oct; 6(10):1961-1970. PubMed ID: 31502419 [TBL] [Abstract][Full Text] [Related]
13. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder]. Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239 [TBL] [Abstract][Full Text] [Related]
14. [Transthyretin familial amyloid polyneuropathy]. Kopishinskaya SV Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):82-89. PubMed ID: 30499502 [TBL] [Abstract][Full Text] [Related]
15. Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review. Martens B; De Pauw M; De Bleecker JL Acta Neurol Belg; 2018 Jun; 118(2):179-185. PubMed ID: 29524093 [TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation. Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715 [TBL] [Abstract][Full Text] [Related]
17. Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy. Li H; Zhang Y; Cao L; Xiong R; Zhang B; Wu L; Zhao Z; Chen SD Drug Des Devel Ther; 2014; 8():2121-8. PubMed ID: 25382970 [TBL] [Abstract][Full Text] [Related]
18. TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients. Luigetti M; Conte A; Del Grande A; Bisogni G; Madia F; Lo Monaco M; Laurenti L; Obici L; Merlini G; Sabatelli M Neurol Sci; 2013 Jul; 34(7):1057-63. PubMed ID: 22592564 [TBL] [Abstract][Full Text] [Related]
19. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro. Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539 [TBL] [Abstract][Full Text] [Related]
20. Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy. Ebenezer GJ; Liu Y; Judge DP; Cunningham K; Truelove S; Carter ND; Sebastian B; Byrnes K; Polydefkis M Ann Neurol; 2017 Jul; 82(1):44-56. PubMed ID: 28598015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]